Literature DB >> 1753027

Chronic sorrow: analysis of the concept.

C S Teel1.   

Abstract

Emotionally close relationships can be disrupted at any time in the life cycle. When a relationship of attachment is disrupted following an event that renders a loved one forever changed from the hoped-for child or from the known person, recurrent sadness, or chronic sorrow, is a frequently encountered response. The genesis of sadness is one's recognition of a negative disparity between the person who was known prior to the onset of disability (or the imagined, hoped-for child) and the now-disabled person. Though each episode of sadness resolves somewhat over time, renewed recognition of a negative disparity in the disabled loved one triggers sadness again. Besides being recurrent, the sadness of chronic sorrow is also permanent, variable in intensity between situations and persons, and interwoven with periods of neutrality, satisfaction and happiness. The concept is analysed and contrasted with the prevalent model of linear, time-bound grief.

Entities:  

Mesh:

Year:  1991        PMID: 1753027     DOI: 10.1111/j.1365-2648.1991.tb01559.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  4 in total

1.  Chronic sorrow: A content analysis of parental differences.

Authors:  E F Hobdell; J A Deatrick
Journal:  J Genet Couns       Date:  1996-06       Impact factor: 2.537

2.  Mothers' Reactions to Their Child's ASD Diagnosis: Predictors That Discriminate Grief from Distress.

Authors:  Heidi A Wayment; Kristina A Brookshire
Journal:  J Autism Dev Disord       Date:  2018-04

3.  Implications of resolving the diagnosis of PKU for parents and children.

Authors:  Bruce Lord; Judy Ungerer; Colin Wastell
Journal:  J Pediatr Psychol       Date:  2008-03-13

4.  Living with a chronic disease: insights from patients with a low socioeconomic status.

Authors:  Lisa Van Wilder; Peter Pype; Fien Mertens; Elke Rammant; Els Clays; Brecht Devleesschauwer; Pauline Boeckxstaens; Delphine De Smedt
Journal:  BMC Fam Pract       Date:  2021-11-18       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.